Advantameds Solutions, Inc. Starts a $25M "Private Offering" Raise

20:00 EDT 10 Aug 2015 | Marketwired

VANCOUVER, BC -- (Marketwired) -- 08/11/15 -- Advantameds Solutions, Inc. announces start to a $25,000,000 US private financial raise ("Private Offering") for the purpose of medical marijuana acquisitions and expansion. Advantameds Solutions, Inc., a Canadian Corporation, (the "Company") together with its wholly owned subsidiary Advantameds Solutions US, Inc., has agreed to participate with a full-scale Colorado commercial horticultural medical marijuana grow facility.

The Company will be utilizing the proceeds of this "Private Offering" to expand the "Colorado Operation" into multiple jurisdictions with expectations of 235,000 plus sq. ft. of indoor grow space. The existing marijuana growing facility has reduced the cost of production per pound in the last 8 years of operations and expects that the increase in the number of growing facilities to tighten the production cost even further.

The Company's CEO Geoff Thompson was quoted saying, "We are not speculators, we are sophisticated business people with a grow partner that has created a true commercial operation that's scalable and sustainable. We hope to become the largest producers of medical marijuana in North America."

The Company started the "Private Offering" raise which is a convertible debt to equity financial instrument. Those who are interested in learning more about Advantameds Solutions, Inc. and its offering, click this link to view our Private Placement Memorandum:

For further information about Advantameds Solution, Inc. and its direct "Private Offering, contact, Geoffrey Thompson,, 800-511-5925, and/or Rich Kaiser, Investor Relations, and/or 757-306-6090,

Forward-looking Statements: This news release contains certain statements that may constitute forward-looking information within the meaning of applicable securities laws. This information includes, but is not limited to: (i) The Company's ability to fully raise $25,000,000; and (ii) legal rules in the medical marijuana industry remaining consistent at the time of this release. Although Advantameds Solutions, Inc. believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because management can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks.

CONTACT: Geoffrey Thomason 800-511-5925 Rich Kaiser 757-306-6090 NEXT ARTICLE

More From BioPortfolio on "Advantameds Solutions, Inc. Starts a $25M "Private Offering" Raise "

Quick Search


Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...